サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566760

キトサン市場：供給源別、用途別：世界の機会分析と産業予測、2024～2033年

Chitosan Market By Source (Shrimp, Squid, Crab, Krill, Others) , By Application (Water treatment, Biomedical and Pharmaceutical, Cosmetics, Food and Beverage, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 300 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
キトサン市場：供給源別、用途別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 300 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

キトサン市場の2023年の市場規模は78億米ドルで、2024～2033年のCAGRは18.7%で、2033年には428億米ドルに達すると予測されています。

キトサンは、ロブスター、エビ、カニなどの貝類の外骨格で合成される天然のバイオポリマーです。このバイオポリマーは、脱アセチル化のプロセスを経てキチンからキトサンに変換されます。キトサンは、生体適合性、生分解性、抗菌活性、抗酸化性など無数の特性を示し、栄養補助食品、食品包装、創傷治療など幅広い用途に適しています。

世界のキトサン市場の成長は、医療、医薬品、飲食品、農業など様々な産業からのキトサン需要の急増が主要要因です。キトサンは無毒性で人体組織に適合するため、創傷被覆材、ドラッグデリバリーシステム、組織工学などの医療製薬用途に適しています。その抗菌性、生体適合性、保水性は創傷治癒やスキンケアを助ける。例えば、欧州疾病予防管理センター（ECDC）の2018年の推定によると、抗生物質耐性菌の感染により毎年3万3,000人近くが死亡しています。このため、天然分子や合成分子から新たな抗菌剤を開発する必要が生じており、これが医療セグメントにおけるキトサンの需要を促進しています。さらに、キトサンは重金属や染料などの汚染物質と結合する能力を発揮するため、水処理のためのサステイナブル選択肢となっています。さらに、世界人口の増加に伴い世界の食糧需要が増加する中、サステイナブル農業の必要性が著しく高まっています。キトサンは従来の農薬に代わるサステイナブル代替品として機能するため、より安全な農法の採用が促進されます。これは、キトサンをベースにした製剤が害虫や病気を効果的に駆除し、化学農薬の必要性を減らし、作物の収量を向上させるという事実に起因しており、農業セグメントでの需要を押し上げています。

キトサンは、脂肪やコレステロールを体内に吸収させる代わりに体外に排出することで、体重減少を助け、コレステロール値を下げると主張する研究もあります。しかし、現在の研究ではこの主張は支持されていないです。2,000年代初頭に行われた臨床試験では、キトサンは便中の脂肪排泄を促進せず、脂肪を捕捉する兆候もないことがわかった。したがって、このような矛盾がキトサン・サプリメントの需要を妨げ、世界市場の成長を著しく阻害しています。キトサンの生産コストが高いことも、世界市場の主要な阻害要因となっています。反対に、キトサンの抗菌特性により、食品の保存期間を延ばす天然保存料としての需要が急増しています。そのため、メーカー各社は食品の腐敗を防ぐため、キトサンをベースとした食用フィルムやコーティング剤の開発に注力しており、予測期間中の市場成長に有益な機会を提供すると期待されています。

キトサン市場は、供給源、用途、地域に区分されます。供給源別では、市場はエビ、イカ、カニ、オキアミ、その他に分類されます。用途別では、水処理、生物医療・医薬品、化粧品、飲食品、その他に分けられます。地域別では、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

供給源別では、エビセグメントが2023年に最も高い市場シェアを占め、2033年その優位性を維持する可能性が高いです。

用途別では、水処理セグメントが2023年の主要株主であり、予測期間中も同じ傾向が続くとみられます。

地域別では、アジア太平洋が予測期間中に最も速い成長を遂げると予想されます。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 製品に含まれる原材料の分析（％単位）
  • 製造能力
  • 製品ベンチマーク/製品仕様と用途
  • 製品ライフサイクル
  • サプライチェーン分析とベンダーのマージン
  • 地域別新規参入企業
  • 平均消費支出
  • 市場参入戦略
  • 製品/セグメント別市場セグメンテーション
  • 主要メーカーの新製品開発/製品マトリックス
  • ペインポイント分析
  • 規制ガイドライン
  • 戦略的提言
  • クライアントの関心に特化した追加企業プロファイル
  • 国別または地域別追加分析-市場規模と予測
  • 平均販売価格分析/プライスポイント分析
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 輸出入分析/データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）
  • 顧客/消費者/原料サプライヤー一覧-バリューチェーン分析
  • 世界/地域/国別レベルでの参入企業の市場シェア分析
  • 一人当たり消費動向
  • SWOT分析
  • 数量市場規模と予測

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 キトサン市場：供給源別

  • 市場概要
  • エビ
  • イカ
  • カニ
  • オキアミ
  • その他

第5章 キトサン市場：用途別

  • 市場概要
  • 水処理
  • 医療医薬品
  • 化粧品
  • 飲食品
  • その他

第6章 キトサン市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国のキトサン市場
    • カナダのキトサン市場
    • メキシコのキトサン市場
  • 欧州
    • 主要市場動向と機会
    • フランスのキトサン市場
    • ドイツのキトサン市場
    • イタリアのキトサン市場
    • スペインのキトサン市場
    • 英国のキトサン市場
    • その他の欧州のキトサン市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国のキトサン市場
    • 日本のキトサン市場
    • インドのキトサン市場
    • 韓国のキトサン市場
    • オーストラリアのキトサン市場
    • その他のアジア太平洋のキトサン市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのキトサン市場
    • 南アフリカのキトサン市場
    • サウジアラビアのキトサン市場
    • その他のラテンアメリカ・中東・アフリカのキトサン市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要企業10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • PRIMEX EHF
  • ADVANCED BIOPOLYMERS AS
  • Panvo Organics Pvt Ltd.
  • Heppe Medical Chitosan GmbH
  • G.T.C. Bio Corporation
  • Kitozyme S.A.
  • Novamatrix
  • Agratech International, Inc.
  • Golden-Shell Pharmaceutical Co. Ltd.
  • Qingdao Yunzhou Biochemistry Co. Ltd.
目次
Product Code: A01409

The chitosan market was valued at $7.8 billion in 2023, and is projected to reach $42.8 billion by 2033, growing at a CAGR of 18.7% from 2024 to 2033.

Chitosan is a natural biopolymer that is synthesized in the outer skeleton of shellfish such as lobster, shrimp, and crab. This biopolymer is derived from chitin through a process of deacetylation, which converts it into chitosan. It exhibits a myriad of properties such as biocompatibility, biodegradability, antimicrobial activity, and antioxidant properties, which make suitable for use in a wide range of applications; for instance, it used in dietary supplements, food packaging, and in wound care.

The growth of the global chitosan market is majorly driven by surge in demand for chitosan from various industries, including healthcare, pharmaceuticals, food & beverages, and agriculture. Chitosan is non-toxic and compatible with human tissues, making it suitable for medical and pharmaceutical applications, including wound dressings, drug delivery systems, and tissue engineering. Its antimicrobial, biocompatible, and water retention properties aid in wound healing and skin care. For instance, according to the 2018 estimates of the European Centre for Disease Prevention and Control (ECDC), nearly 33,000 individuals die every year due to infection with antibiotic-resistant bacteria. This has necessitated the development of developing new antimicrobials from natural and synthetic molecules, which, in turn, has fostered the demand for chitosan in the medical sector. In addition, chitosan's exhibits the ability to bind with contaminants, including heavy metals and dyes, which makes it a sustainable choice for water treatment. In addition, as the world's food demand is aligning with the increasing global population, the need for sustainable agricultural practices has increased notably. Chitosan serves as a sustainable alternative to conventional agrochemicals, thus fostering the adoption of safer agricultural practices. This is attributed to the fact that chitosan-based formulations can effectively control pests and diseases, reduce the need for chemical pesticides, and improve crop yields, which boosts its demand in the agricultural sector.

Some studies claim that chitosan assists in weight loss and lowers cholesterol levels by eliminating fat and cholesterol from the body instead of allowing the body to absorb them. However, current studies do not support this claim. Clinical trials conducted in the early 2000s found that chitosan did not facilitate fat excretion in stool, and there is no indication that it traps fat. Thus, such discrepancies hamper the demand for chitosan supplements, which significantly hampers the growth of the global market. High production costs of chitosan further acts as a key deterrent factor of the global market. Contrarily, surge in demand for chitosan as a natural preservative to extend the shelf life of food products due to its antimicrobial properties. Thus, manufacturers are focusing on the development of edible chitosan-based edible films and coatings to prevent the spoilage of food products, which is expected to offer remunerative opportunities for the growth of the market during the forecast period.

The chitosan market is segmented into source, application, and region. By source, the market is classified into shrimp, squid, crab, krill, and others. On the basis of application, it is divided into water treatment, biomedical & pharmaceutical, cosmetics, food & beverage, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By source, the shrimp segment held the highest market share in 2023 and is likely to retain its dominance by 2033.

Depending on application, the water treatment segment was the major shareholder in 2023 and is expected to continue the same trend during the forecast period.

Region wise, Asia-Pacific is expected to experience the fastest growth during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global chitosan market include PRIMEX EHF, ADVANCED BIOPOLYMERS AS, Panvo Organics Pvt Ltd., Heppe Medical Chitosan GmbH, G.T.C. Bio Corporation, Kitozyme S.A., Novamatrix, Agratech International, Inc., Golden-Shell Pharmaceutical Co. Ltd., and Qingdao Yunzhou Biochemistry Co. Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Analysis of raw material in a product (by %)
  • Manufacturing Capacity
  • Product Benchmarking / Product specification and applications
  • Product Life Cycles
  • Supply Chain Analysis & Vendor Margins
  • Upcoming/New Entrant by Regions
  • Average Consumer Expenditure
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Pain Point Analysis
  • Regulatory Guidelines
  • Strategic Recommendations
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • List of customers/consumers/raw material suppliers- value chain analysis
  • Market share analysis of players at global/region/country level
  • Per Capita Consumption Trends
  • SWOT Analysis
  • Volume Market Size and Forecast

Key Market Segments

By Source

  • Shrimp
  • Squid
  • Crab
  • Krill
  • Others

By Application

  • Water treatment
  • Biomedical and Pharmaceutical
  • Cosmetics
  • Food and Beverage
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • PRIMEX EHF
    • ADVANCED BIOPOLYMERS AS
    • Panvo Organics Pvt Ltd.
    • Heppe Medical Chitosan GmbH
    • G.T.C. Bio Corporation
    • Kitozyme S.A.
    • Novamatrix
    • Agratech International, Inc.
    • Golden-Shell Pharmaceutical Co. Ltd.
    • Qingdao Yunzhou Biochemistry Co. Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CHITOSAN MARKET, BY SOURCE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Source
  • 4.2. Shrimp
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Squid
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Crab
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Krill
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: CHITOSAN MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Water Treatment
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Biomedical And Pharmaceutical
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Cosmetics
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Food And Beverage
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: CHITOSAN MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Source
    • 6.2.3. Market Size and Forecast, By Application
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Chitosan Market
      • 6.2.5.1. Market Size and Forecast, By Source
      • 6.2.5.2. Market Size and Forecast, By Application
    • 6.2.6. Canada Chitosan Market
      • 6.2.6.1. Market Size and Forecast, By Source
      • 6.2.6.2. Market Size and Forecast, By Application
    • 6.2.7. Mexico Chitosan Market
      • 6.2.7.1. Market Size and Forecast, By Source
      • 6.2.7.2. Market Size and Forecast, By Application
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Source
    • 6.3.3. Market Size and Forecast, By Application
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Chitosan Market
      • 6.3.5.1. Market Size and Forecast, By Source
      • 6.3.5.2. Market Size and Forecast, By Application
    • 6.3.6. Germany Chitosan Market
      • 6.3.6.1. Market Size and Forecast, By Source
      • 6.3.6.2. Market Size and Forecast, By Application
    • 6.3.7. Italy Chitosan Market
      • 6.3.7.1. Market Size and Forecast, By Source
      • 6.3.7.2. Market Size and Forecast, By Application
    • 6.3.8. Spain Chitosan Market
      • 6.3.8.1. Market Size and Forecast, By Source
      • 6.3.8.2. Market Size and Forecast, By Application
    • 6.3.9. UK Chitosan Market
      • 6.3.9.1. Market Size and Forecast, By Source
      • 6.3.9.2. Market Size and Forecast, By Application
    • 6.3.10. Rest of Europe Chitosan Market
      • 6.3.10.1. Market Size and Forecast, By Source
      • 6.3.10.2. Market Size and Forecast, By Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Source
    • 6.4.3. Market Size and Forecast, By Application
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Chitosan Market
      • 6.4.5.1. Market Size and Forecast, By Source
      • 6.4.5.2. Market Size and Forecast, By Application
    • 6.4.6. Japan Chitosan Market
      • 6.4.6.1. Market Size and Forecast, By Source
      • 6.4.6.2. Market Size and Forecast, By Application
    • 6.4.7. India Chitosan Market
      • 6.4.7.1. Market Size and Forecast, By Source
      • 6.4.7.2. Market Size and Forecast, By Application
    • 6.4.8. South Korea Chitosan Market
      • 6.4.8.1. Market Size and Forecast, By Source
      • 6.4.8.2. Market Size and Forecast, By Application
    • 6.4.9. Australia Chitosan Market
      • 6.4.9.1. Market Size and Forecast, By Source
      • 6.4.9.2. Market Size and Forecast, By Application
    • 6.4.10. Rest of Asia-Pacific Chitosan Market
      • 6.4.10.1. Market Size and Forecast, By Source
      • 6.4.10.2. Market Size and Forecast, By Application
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Source
    • 6.5.3. Market Size and Forecast, By Application
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Chitosan Market
      • 6.5.5.1. Market Size and Forecast, By Source
      • 6.5.5.2. Market Size and Forecast, By Application
    • 6.5.6. South Africa Chitosan Market
      • 6.5.6.1. Market Size and Forecast, By Source
      • 6.5.6.2. Market Size and Forecast, By Application
    • 6.5.7. Saudi Arabia Chitosan Market
      • 6.5.7.1. Market Size and Forecast, By Source
      • 6.5.7.2. Market Size and Forecast, By Application
    • 6.5.8. Rest of LAMEA Chitosan Market
      • 6.5.8.1. Market Size and Forecast, By Source
      • 6.5.8.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. PRIMEX EHF
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. ADVANCED BIOPOLYMERS AS
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Panvo Organics Pvt Ltd.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Heppe Medical Chitosan GmbH
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. G.T.C. Bio Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Kitozyme S.A.
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Novamatrix
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Agratech International, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Golden-Shell Pharmaceutical Co. Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Qingdao Yunzhou Biochemistry Co. Ltd.
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments